According to Mirati Therapeutics's latest financial reports the company's current earnings (TTM) are -A$1.15 B. In 2022 the company made an earning of -A$1.14 B a decrease over its 2021 earnings that were of -A$0.86 B.The earnings displayed on this page is the company's Pretax Income.